Systemic Sclerosis: Clinical Trials

12 trials for Systemic Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown. 12 Phase 2, 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 12
Phase 13Unknown 3
Phase 32Unknown 2

Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis
Topical 25% sodium metabisulfite (SM) in pediatric cold cream, Placebo - Systemic Sclerosis, Calcinosis
Phase 1 / Phase 2UnknownPontificia Universidad Catolica de Chile202024-01-022023-12-04
Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells
Autologous Regulatory Т-cells, Standard treatment according to the clinical protocols - Systemic Sclerosis
Phase 1 / Phase 2UnknownInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus302022-09-012022-09-14
COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases
COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease
Phase 2 / Phase 3UnknownPaul R Fortin2872022-03-092023-01-17
Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
Mycophenolate Mofetil 500mg - Systemic Sclerosis, Limited Cutaneous Systemic Sclerosis
Phase 2UnknownUniversity College, London1202021-12-082023-07-27
A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis
Sirolimus - Systemic Sclerosis
Phase 2UnknownPeking University People's Hospital722018-06-012017-12-07
Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
Pirfenidone, Placebo oral capsule, Steroids - Systemic Sclerosis
Phase 2 / Phase 3UnknownRenJi Hospital722017-05-012017-03-01
SCLERoderma et Adipose-DErived Stroma Cells
Stromal Vascular fraction, Ringer lactate - Systemic Sclerosis
Phase 2UnknownAssistance Publique Hopitaux De Marseille442017-01-012016-08-15
CSL Behring Sclero XIII
Fibrogammin®P, coagulation factor XIII concentrate (Human), 0.9% sodium chloride - Systemic Sclerosis
Phase 2UnknownUniversity College, London262015-09-012016-05-30
Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease
Vivomixx probiotics - Systemic Sclerosis
Phase 2UnknownSingapore General Hospital402013-05-012018-09-10
Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)
Allogeneic Mesenchymal Stem Cells (AlloMSC) - Systemic Sclerosis, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School202009-08-012009-08-20
Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement
Imatinib - Systemic Sclerosis
Phase 2UnknownAzienda Ospedaliera Universitaria Policlinico302009-02-012009-09-03
AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
Hyperimmune caprine serum, Albumin - Systemic Sclerosis
Phase 2UnknownDaval International Limited202008-12-012011-08-18

Narrower conditions

Scleroderma, Systemic (12)  ·  Scleroderma, Diffuse (2)  ·  Arthritis, Rheumatoid (1)  ·  Calcinosis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  MASS syndrome (1)  ·  Raynaud Disease (1)  ·  Scleroderma, Limited (1)  ·  Systemic Vasculitis (1)  ·  Undifferentiated Connective Tissue Diseases (1)  ·  digital ulcers (1)

Broader conditions

Connective Tissue Diseases (12)  ·  Skin Diseases (12)  ·  Skin and Connective Tissue Diseases (12)  ·  Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Calcium Metabolism Disorders (1)  ·  Embolism and Thrombosis (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Livedoid Vasculopathy (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Albumins (1)  ·  COVID-19 Vaccines (1)  ·  Factor VIII (1)  ·  Factor XIII (1)  ·  Imatinib Mesylate (1)  ·  Mycophenolic Acid (1)  ·  Ringer's Lactate (1)  ·  Saline Solution (1)  ·  Sirolimus (1)  ·  Sodium Chloride (1)  ·  Steroids (1)  ·  pirfenidone (1)  ·  sodium metabisulfite (1)

Sponsors

University College, London (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Azienda Ospedaliera Universitaria Policlinico (1)  ·  Daval International Limited (1)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1)  ·  Paul R Fortin (1)  ·  Peking University People's Hospital (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  RenJi Hospital (1)  ·  Singapore General Hospital (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

United Kingdom (3)  ·  China (2)  ·  Belarus (1)  ·  Canada (1)  ·  Chile (1)  ·  France (1)  ·  Italy (1)  ·  Singapore (1)

Top investigators

Andrei Hancharou, Dr (1)  ·  Antonia Valenzuela, MD, MS (1)  ·  Armando Gabrielli, MD (1)  ·  Christopher Denton (1)  ·  Christopher Denton, PhD (1)  ·  Christopher P Denton, PhD FRCP (1)  ·  Kanstantsin Chyzh, Dr (1)  ·  Mu Rong, Poster (1)  ·  Paul R Fortin, MD,MPH,FRCPC (1)

Results publications

PMID 22542159, PMID 24067785, PMID 25007944, PMID 28270187, PMID 28724445, PMID 31208714, PMID 38206544

NIH funding

2014 (1), 2019 (1)